Search Results

DiFusion Technologies, an industry leader in advanced biomaterials for surgical implants, announced today the results of a recent case series noting the benefits of the company’s proprietary ZFUZE™ technology.

DiFusion Technologies, maker of the ZFUZE™ suite of surgical polymers, today announced the addition of Todd Potokar to its Board of Directors.

U.S. Army Institute of Surgical Research to conduct key studies intended to further our knowledge of the effects of Claromer technology

DiFusion Technologies, Inc. today announced landmark data for the company’s ZFUZE Surgical Polymer and how it compares to traditional biomaterials like Titanium and Poly-Ether-Ether-Ketone (PEEK). The data and the importance of the immune system response in new technologies such as ZFUZE were debated at the International Society for Advancement of Spine Surgery – ISASS in late May in Miami.

The FDA’s guidance on AI in drug development points to potentially life-threatening consequences of the technology, highlighting the importance of providing the regulator with detailed information regarding models’ development and maintenance.

DiFusion Inc, unveiled groundbreaking Osteoimmunology data at the North American Spine Society 2020 Annual Meeting demonstrating the superiority of the new biomaterial ZFUZE over Nano-Surfaced Titanium and conventional PEEK materials